Targeting MAP1A overcomes immunotherapy resistance in triple-negative breast cancer by restoring tumor antigen presentation via JAK1-STAT1 inhibition. // Med. – URL: https://www.sciencedirect.com/science/article/pii/S2666634026003636?dgcid=rss_sd_all
Targeting MAP1A overcomes immunotherapy resistance in triple-negative breast cancer by restoring tumor antigen presentation via JAK1-STAT1 inhibition. Med. https://www.sciencedirect.com/science/article/pii/S2666634026003636?dgcid=rss_sd_all
“Targeting MAP1A overcomes immunotherapy resistance in triple-negative breast cancer by restoring tumor antigen presentation via JAK1-STAT1 inhibition.” Med.
@article{article94660,
title = {Targeting MAP1A overcomes immunotherapy resistance in triple-negative breast cancer by restoring tumor antigen presentation via JAK1-STAT1 inhibition},
journal = {Med},
url = {https://www.sciencedirect.com/science/article/pii/S2666634026003636?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...